Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: Analysis of vitreous samples

Cytokine

Volumn 49, Issue 3, 2010, Pages 269-274

  Adamiec Mroczek, J ^a   Oficjalska Mlynczak J ^a   Misiuk Hojlo M ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Diabetic retinopathy; Endothelin 1; IL 6; TNF ; Vitreous

Indexed keywords

CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; HEMOGLOBIN A1C; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE EXAMINATION; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; VITRECTOMY; VITREOUS BODY;

AGED; CYTOKINES; DIABETIC RETINOPATHY; E-SELECTIN; ENDOTHELIN-1; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; VITREOUS BODY; VON WILLEBRAND FACTOR;

EID: 75449101393     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.11.004     Document Type: Article

References (36)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
2. Hammes H.P., Du X., Edelstein D., et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 9 (2003) 294-299
3. Singh R., Barden A., Mori T., and Beilin L. Advanced glycation end-products: a review. Diabetologia 44 (2001) 129-146
4. Gabbay K.H. Hyperglycemia, polyol metabolism, and complications of diabetes mellitus. Ann Rev Med 26 (1975) 521-536
5. Schalkwijk C.G., and Stehouwer C.D.A. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci 109 (2005) 143-159
6. Stern D.M., Yan S.D., Yan S.F., and Schmidt A.M. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Ageing Res Rev 1 (2002) 1-15
7. Chen S., Apostolova M.D., Cherian M.G., and Chakrabarti S. Interaction of endothelin-1 with vasoactive factors in mediating glucose-induced increased permeability in endothelial cells. Lab Invest 80 (2000) 1311-1321
8. Ishii H., Jirousek M.R., Koya D., et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKCß inhibitor. Science 272 (1996) 728-731
9. Rychlik-Golema W., Adamiec R., Bednarska-Chabowska D., and Adamiec J. The Raynaud's phenomenon: still current clinical problem. Acta Angiologica 8 (2002) 66-68
10. De Juan J.A., Moya F.J., Ripodas A., Bernal R., Fernandez-Cruz A., and Fernandez-Durango R. Changes in the density and localization of endothelin receptors in the early stages of rat diabetic retinopathy and the effect of insulin treatment. Diabetologia 43 (2000) 773-785
11. Bednarska-Chabowska D., Adamiec R., Rychlik-Golema W., and Adamiec J. Selected problems of endothelial functions. I. The role of endothelium in maintaining the hematological and circulatory balance. Pol Merkur Lek 12 70 (2002) 322-327
12. Eringa E.C., Stehouwer C.D., Nieuw Amerongen G.P., Ouwehand L., Westerhof N., and Sipkema P. Vasoconstrictor effects of insulin in skeletal muscle arterioles are mediated by ERK1/2 activation in endothelium. Am J Physiol Heart Circ Physiol 287 (2004) H2043-H2048
13. Shinohara M., Thornalley P.J., Giardino I., et al. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 101 5 (1998) 1142-1147
14. Bourajjaj M., Stehouwer C.D., van Hingsbergh V.W., and Schalkwijk C.G. Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitus. Biochem Soc Trans 31 (2003) 1400-1402
15. Frank R.N. Diabetic retinopathy. N Engl J Med 350 (2004) 48-58
16. Chen S., Jim B., and Ziyadeh F.N. Diabetic nephropathy and transforming growth factor-ß: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nepfhrol 23 (2003) 532-543
17. Fong D.S., Aiello L.P., Ferris III F.L., and Klein R. Diabetic retinopathy. Diabetes Care 27 (2004) 2540-2553
18. Monaco C., and Paleolog E. Nuclear factor kB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc Res 61 (2004) 671-682
19. American Diabetes Association. Clinical practice recommendations. Diabetes Care 2004;27.
20. International Diabetes Federation. Global guidelines for type 2 diabetes. IDF Brussels 2005.
21. Roldán-Pallarés M., Rollin R., Martinez-Montero J.C., Fernández-Cruz A., Bravo-Llata C., and Fernández-Durango R. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy. Retina 27 (2007) 222-235
22. Takahashi K., Ghatei M.A., Lam H.C., O'Halloran D.J., and Bloom S.R. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33 (1990) 306-310
23. Laurenti O., Vingolo E.M., Desideri G.B., et al. Increased levels of plasma endothelin-1 in non-insulin dependent diabetic patients with retinopathy but without other diabetes-related organ damage. Exp Clin Endocrinol Diabetes 105 (1997) 40-42
24. Takahashi M., Matsushita Y., Ijima Y., and Tanzawa K. Purification and characterization of endothelin-converting enzyme from rat lung. J Biol Chem 268 (1993) 21394-21398
25. De Juan J.A., Moya F.J., Ripodas A., Bernal R., Fernandez-Cruz A., and Fernandez-Durango R. Changes in the density and localisation of endothelin receptors in the early stages of rat diabetic retinopathy and the effect of insulin treatment. Diabetologia 43 6 (2000) 773-785
26. Koya D., and King G.L. Protein kinase C activation and the development of diabetic complications. Diabetes 47 6 (1998) 859-866
27. Park J.Y., Takahara N., Gabriele A., et al. Induction of endothelin-1 expression by glucose. An effect of protein kinase c activation. Diabetes 49 (2000) 1239-1248
28. Makino A., and Kamata K. Elevated plasma endothelin-1 level in streptozotocin induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1. Br J Pharmacol 123 (1998) 1065-1072
29. Takaki C., Bursell S.E., Lin Y.W., et al. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci 37 (1996) 2018-2054
30. Yuuki T., Kanda T., Kimura Y., et al. Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications 15 5 (2001) 257-259
31. Canataroglu H., Varinli I., Ozcan A.A., Canataroglu A., Doran F., and Varinli S. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy. Ocul Immunol Inflamm 13 5 (2005) 375-381
32. Limb G.A., Hollifield R.D., Webster L., Charteris D.G., and Chignell A.H. Soluble TNF receptors in vitreoretinal proliferative disease. Invest Ophthalmol Vis Sci 42 7 (2001) 1586-1591
33. Nakamura N., Hasegawa G., Obayashi H., et al. Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy. Diabetes Res Clin Pract 61 2 (2003) 93-101
34. Kawashima M., Shoji J., Nakajima M., Kamura Y., and Sato Y. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy. Jpn J Ophthalmol 51 (2007) 100-104
35. Matsuura A., Yamochi W., and Hirata K. Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression. Hypertension 32 (1998) 89-95
36. Yokota T., Ma R.C., Park J.Y., and Isshiki K. Role of protein kinase c on the expression of platelet-derived growth factor and ednothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes. Diabetes 52 3 (2003) 838-846